OSR Health (OSRHW) Intangibles (2024 - 2026)
OSR Health (OSRHW) posted Intangibles of $139.0 million for Q1 2026, down 2.45% sequentially from $142.5 million in Q4 2025, and down 4.92% YoY from $146.2 million in Q1 2025.
OSR Health (OSRHW) Intangibles (2024 - 2026) Analysis & Trends
OSR Health has reported Intangibles for 3 years, with the latest figure at $139.0 million in Q1 2026.
- Quarterly Intangibles fell 4.92% year-over-year to $139.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139.0 million (down 4.92% YoY) and the FY2025 annual result came in at $142.5 million, down 3.78% from the prior year.
- Intangibles retreated to $139.0 million in Q1 2026 per OSRHW's latest filing, from $142.5 million in the prior quarter.
- Over five years, Intangibles peaked at $155.6 million in Q2 2025 and troughed at $139.0 million in Q1 2026.
- A 3-year average of $146.6 million and a median of $147.1 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2025 and 2026: Intangibles decreased 3.78% in 2025, then slipped 4.92% in 2026.
- Over 3 years, Intangibles stood at $148.1 million in 2024, then dropped by 3.78% to $142.5 million in 2025, then fell by 2.45% to $139.0 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $139.0 million, $142.5 million, and $148.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | - |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 93.49 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 163.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.97 Mn |
| Dec 31, 2025 | 142.46 Mn |
| Sep 30, 2025 | 148.15 Mn |
| Jun 30, 2025 | 155.59 Mn |
| Mar 31, 2025 | 146.16 Mn |
| Dec 31, 2024 | 148.06 Mn |